Livzon Pharma Convenes 24 Sep 2026 EGM to Approve Special Interim Dividend

Bulletin Express
09/08

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has issued a notice to convene its first Extraordinary General Meeting (EGM) of 2026 on 24 September 2026 at 2:00 p.m. in Zhuhai, Guangdong. The single agenda item is an ordinary resolution to approve a 2026 Special Interim Dividend for shareholders.

Key timetable • 18 Sep 2026 – Record date for determining shareholders entitled to attend and vote at the EGM. • 24 Sep 2026 – EGM date; exchange rate for HKD dividend conversion to be fixed at the PBOC RMB/HKD central parity rate on this date. • 13 Oct 2026 – Record date for A-share holders entitled to the Special Interim Dividend. • 15 Oct 2026 – Record date for H-share holders entitled to the Special Interim Dividend; deadline (4:30 p.m.) for lodging H-share transfer documents with Tricor Investor Services.

Dividend currency • A-share investors will receive the Special Interim Dividend in renminbi (RMB). • H-share investors will receive the dividend in Hong Kong dollars, converted from RMB at the 24 September 2026 PBOC central parity rate.

Tax treatment • Overseas individual H-shareholders: 20% individual income tax to be withheld by the company, in line with MOF and SAT Announcement 2026-No. 27. • Non-resident enterprise H-shareholders: 10% corporate income tax to be withheld under Guo Shui Han [2008] No. 897. • Southbound Trading Link investors: domestic individuals and securities investment funds subject to a 20% withholding; domestic enterprise investors to self-declare and pay taxes.

Shareholders may appoint one or more proxies to attend and vote, with proxy forms due 24 hours before the meeting. Completion of a proxy form does not preclude shareholders from attending the meeting in person.

Livzon Pharma’s board currently comprises two executive directors, three non-executive directors, one employee representative director, and four independent non-executive directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10